Lam Research (NASDAQ:LRCX) Stock Price Down 4.2% – What’s Next?

Shares of Lam Research Corporation (NASDAQ:LRCX) traded down 4.2% on Thursday . The stock traded as low as $230.70 and last traded at $239.07. 10,622,218 shares traded hands during mid-day trading, a decline of 15% from the average session volume of 12,474,908 shares. The stock had previously closed at $249.48.

Analyst Ratings Changes

LRCX has been the topic of a number of research reports. Summit Insights raised Lam Research from a “hold” rating to a “buy” rating in a research note on Thursday, January 29th. Morgan Stanley upped their price objective on Lam Research from $244.00 to $254.00 and gave the company an “equal weight” rating in a research note on Wednesday. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Lam Research from $260.00 to $290.00 and gave the stock a “buy” rating in a research note on Thursday, January 29th. Wells Fargo & Company raised their target price on Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Finally, Wall Street Zen cut shares of Lam Research from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, Lam Research has a consensus rating of “Moderate Buy” and a consensus target price of $245.19.

Lam Research Trading Down 4.2%

The stock has a market cap of $298.54 billion, a PE ratio of 48.99, a PEG ratio of 2.62 and a beta of 1.78. The stock’s fifty day moving average price is $214.18 and its 200 day moving average price is $163.37. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. The firm had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business’s quarterly revenue was up 22.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, sell-side analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be given a dividend of $0.26 per share. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. Lam Research’s dividend payout ratio (DPR) is currently 21.31%.

Insider Transactions at Lam Research

In related news, Director Eric Brandt sold 35,000 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director directly owned 253,705 shares in the company, valued at approximately $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.31% of the company’s stock.

Institutional Trading of Lam Research

A number of institutional investors have recently bought and sold shares of LRCX. PMV Capital Advisers LLC bought a new position in Lam Research in the 4th quarter valued at $25,000. Stance Capital LLC bought a new position in shares of Lam Research during the third quarter valued at approximately $26,000. Howard Hughes Medical Institute purchased a new position in shares of Lam Research in the 2nd quarter valued at $27,000. Triumph Capital Management bought a new position in Lam Research in the third quarter worth about $27,000. Finally, Mcguire Capital Advisors Inc. purchased a new stake in Lam Research during the fourth quarter valued at approximately $27,000. 84.61% of the stock is currently owned by institutional investors.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.